PERPUSTAKAAN SEKOLAH TINGGI ILMU KESEHATAN SAMARINDA
REPOSITORY
Select Language

Simple Search

Advanced Search
Title :
Author(s) :
  • SEARCHING...

Subject(s) :
  • SEARCHING...

ISBN/ISSN :
GMD : Collection Type : Location :
License

This Software is Released Under GNU GPL License Version 3.

indexed
Visitors
Flag Counter

Statistic
Total Collection:
Title Marmara Pharmaceutical Journal of Research in Pharmacy Journal of Research in Pharmacy 2020 , Vol 24 Issue 2
Edition Vol 24 Issue 2
Call Number
ISBN/ISSN
Author(s)
Subject(s)
Classification
Series Title
GMD Karya Tulis Ilmiah
Language Indonesia
Publisher
Publishing Year
Publishing Place
Collation
Abstract/Notes ABSTRACT: The oral hypoglycaemic agents as well as injectable insulin does not significantly alter the oxidative
stress in the diabetes mellitus patients. Being an antioxidant Vitamin C (ascorbic acid) might help in tackling the
adversities of reactive oxygen species. A randomized placebo controlled study was carried out with parallel
assignment of both the test group and control group of patients. The intervention model included metformin 500mg
twice daily and a placebo once daily for control group. Alternatively, Vitamin C chewable tablets were given for the
other group along with metformin 500mg twice daily. Our study postulates that there is a significant reduction in
the fasting blood glucose, glycosylated haemoglobin levels, troponin T levels and Framingham risk score in
participants who received ascorbic acid supplementation along with regular metformin. The supplementation of
Vitamin C along with Metformin was well tolerated and did not cause any serious adverse drug reactions. The
cheaper cost adjuvant approach with Vitamin C may be beneficial in patients in reducing the cardiovascular risk as
well as to maintain an appropriate glycaemic control
KEYWORDS: Diabetes Mellitus; ascorbic acid; glycemic control; cardiovascular risk.
Specific Detail Info
Image
File Attachment
LOADING LIST...
Availability
LOADING LIST...
  Back To Previous